Abstract
Glioblastoma multiforme is considered the most aggressive type of brain tumor and presents limitations in conventional therapies, due to the difficulty of drugs in crossing the blood-brain barrier (BBB), requiring high doses to obtain the therapeutic effect, and thus contributing to the occurrence of numerous adverse effects. Temozolomide is the gold standard chemotherapy drug for treatme…